TI

Tube Investments of India Ltd

Q4 FY26Auto Components

TIINDIA Q4 FY26 Results & Concall Highlights: Key Takeaways

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price3,258
Market cap₹57.1K Cr
P/E92.3
Updated3 Jul 2026
Read5 min read

What the Q4 FY26 call signalled

2 of 4 strong

RevenueRank 3
MarginRank 3
CapexYes
Order bookYes

Not discussed on this call: fundraise.

The short version

- Engineering business volume growth is in line with sales growth; Q4 FY2026 volume growth matched revenue growth. - TI Medical business is expected to grow at 15-20% year-on-year, driven by new product development and recent acquisition (Medicura asset purchase). - The engineering business shows volume growth in line with revenue growth; management remains bullish on volume growth despite macro challenges. - Metal formed products (MFP) segment is currently sluggish but expected to recover after overcoming some customer-specific issues. - Electric Vehicle (EV) business sees strong order books for heavy trucks and small commercial vehicles with ongoing cost reduction and localization efforts aimed at scaling up. - Challenges remain in EV deployment related to financing and charging infrastructure; however, management is optimistic about resolving these and scaling volumes in Q1 and Q2 FY2027. - Capex guidance: Rs.

From Tube Investments of India Ltd's Q4 FY26 earnings-call transcript · updated 3 Jul 2026.

Revenue & Sales Performance

Rank 3
  • Engineering business volume growth is in line with sales growth; Q4 FY2026 volume growth matched revenue growth.
  • Volume growth remains strong entering Q1 FY2027 despite macro challenges; commodity price inflation is partially passed through; fuel cost pressures are being addressed.
  • EV business sees strong order book and increasing demand, especially in heavy and small commercial vehicles; deployment challenges (financing and charging infrastructure) are being worked on, with expected scaling in Q1 and Q2 FY2027.
  • Medical devices (TI Medical) expects 15-20% year-on-year growth; recent acquisition (Medicura asset purchase) to add growth from Q1/Q2 FY2027 as commercial production begins.
  • Railway business scale-up is ongoing with product approvals in progress; progress expected over 2-3 quarters.
  • Overall, bullish on volume and revenue growth with strategic investments and cost reduction initiatives to support scaling.

Profitability & Margins

See what Tube Investments of India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes
  • Capex guidance for FY2027 standalone business is around Rs. 300 Crores to Rs. 350 Crores.
  • Additional investment of approximately Rs. 300 Crores is expected for subsidiaries, including TI Clean Mobility Private Limited (TICMPL) and TI Medical.
  • Recent strategic acquisition: Purchase of Medicura facility at Ambala for IV cannula business; plant approval is in progress and commercial production expected in Q1/Q2 FY2027.
  • CDMO business plant at Naidupet is in final commissioning with commercial production slated to start next quarter.
  • Future expansion plans are under consideration, like further ramp-up at CRSS plant in Nasik and steel tube facilities in Western India once current capacities reach full utilization.

Top-ranked in Auto Components

Ranked on what management guided this quarter

5x potential
1Divgi Torq
Rev 1Mar 3
2OBSC Perfection
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Tube Investments of India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Yes
  • Tube Investments of India is currently sitting on a very good order book for their electric vehicles, especially in the heavy truck segment and small commercial vehicle segment (Page 6-7).
  • They expect to deploy these trucks in Q1 and Q2 of FY2027, indicating a healthy pipeline of pending orders (Page 6).
  • For the three-wheeler business, after resolving supply issues, there is confidence in a good scale-up of volumes, reflecting strong demand/orders (Page 7).
  • The company is working on orders related to their swap battery technology, particularly for applications like ports (Page 7).
  • No specific numeric order book figures shared, but demand is strong with ongoing scaling initiatives across EV and other segments.

Tube Investments of India Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹6.2K Cr, net profit ₹234 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Auto Components this season

  • Precision Camshafts Ltd (Q4 FY26)

    Precision Camshafts Limited has a healthy order book of INR1,500 crores to be executed over the next 5-6 years, supporting long-term growth. Key concall…

  • Kranti Industries Ltd (Q4 FY26)

    FY26 marked crossing ₹100 crore consolidated revenue milestone, with optimism for continued ramp-up. Key concall takeaways from Kranti Industrie's Q4 FY26…

  • CEAT Ltd (Q4 FY26)

    Price increases planned: around 5% taken between March-April; additional 5% staggered through May-June, totaling a 10% replacement price hike. Key concall…

  • Balkrishna Industries Ltd (Q4 FY26)

    OHT business volumes increased by 5% in the latest quarter; growth momentum seen in H2 FY '26 over H1. Key concall takeaways from Balkrishna Inds's Q4 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Tube Investments of India Ltd Q1 FY27 results?

- Engineering business volume growth is in line with sales growth; Q4 FY2026 volume growth matched revenue growth. - TI Medical business is expected to grow at 15-20% year-on-year, driven by new product development and recent acquisition (Medicura asset purchase). - The engineering business shows volume growth in line with revenue growth; management remains bullish on volume growth despite macro challenges. - Metal formed products (MFP) segment is currently sluggish but expected to recover after overcoming some customer-specific issues. - Electric Vehicle (EV) business sees strong order books for heavy trucks and small commercial vehicles with ongoing cost reduction and localization efforts aimed at scaling up. - Challenges remain in EV deployment related to financing and charging infrastructure; however, management is optimistic about resolving these and scaling volumes in Q1 and Q2 FY2027. - Capex guidance: Rs.

What is Tube Investments of India Ltd share price analysis?

Tube Investments of India Ltd currently shows a below-average growth signal. The stock trades at a P/E of 92.3 with a market cap of ₹57,057. Investors should review the full earnings analysis for detailed insights.

Is Tube Investments of India Ltd planning capital expenditure?

- Capex guidance for FY2027 standalone business is around Rs.

Keep Tube Investments of India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.